AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 263: F573-F580, 1992;
0363-6127/92 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chatziantoniou, C.
Right arrow Articles by Arendshorst, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chatziantoniou, C.
Right arrow Articles by Arendshorst, W. J.

AJP - Renal Physiology, Vol 263, Issue 4 573-F580, Copyright © 1992 by American Physiological Society


ARTICLES

Impaired ability of prostaglandins to buffer renal vasoconstriction in genetically hypertensive rats

C. Chatziantoniou and W. J. Arendshorst
Department of Physiology, University of North Carolina, Chapel Hill 27599-7545.

The purpose of this study was to gain insight into the mechanism(s) responsible for the exaggerated angiotensin II (ANG II)-induced renal vasoconstriction during the development of hypertension. In previous studies we observed that ANG II produces a twofold larger decrease in renal blood flow (RBF) in spontaneously hypertensive (SHR) compared with Wistar-Kyoto (WKY) rats before but not after cyclooxygenase inhibition. We suggested that this strain difference could be attributed to differences in renal prostaglandin (PG) levels and/or action. To evaluate these possibilities, measurements of RBF were made in 6-wk-old, anesthetized SHR and WKY pretreated with indomethacin. ANG II was injected intrarenally before and during continuous intrarenal infusion of a low dose of PGE2, viprostol (PGE2 analogue), PGI2, iloprost (PGI2 analogue), and bradykinin. In the control period ANG II reduced RBF by 50% in both strains. Infusion of PGs reduced the vasoconstrictor effect of ANG II in WKY, but had no effect in SHR. In contrast, infusion of bradykinin blunted the ANG II-induced vasoconstriction to a similar degree in both WKY and SHR. To investigate whether this lack of protection in SHR is due to strain differences in the number and/or affinity of renal receptors of PGs, radiolabeled ligand binding studies for PGE2 and PGI2 receptors were undertaken in glomeruli isolated from young WKY and SHR. Scatchard analysis revealed a single, high-affinity receptor site for PGE2 that was similar in both strains of rats. Both strains also exhibited a single, high-affinity PGI2 receptor site. No differences were observed in the PGE2 or PGI2 receptor number between WKY and SHR.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
O. B. Vagnes, B. M. Iversen, and W. J. Arendshorst
Short-term ANG II produces renal vasoconstriction independent of TP receptor activation and TxA2/isoprostane production
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F860 - F867.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. Joly, R. Seqqat, B. Flamion, N. Caron, A. Michel, J. D. Imig, and R. Kramp
Increased renal vascular reactivity to ANG II after unilateral nephrectomy in the rat involves 20-HETE
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R977 - R986.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
O. B. Vagnes, F. H. Hansen, J. J. Feng, B. M. Iversen, and W. J. Arendshorst
Enhanced Ca2+ response to AVP in preglomerular vessels from rats with genetic hypertension during different hydration states
Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1249 - F1256.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Just, A. J. M. Olson, J. R. Falck, and W. J. Arendshorst
NO and NO-independent mechanisms mediate ETB receptor buffering of ET-1-induced renal vasoconstriction in the rat
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1168 - R1177.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
O. B. Vagnes, F. H. Hansen, R. E. F. Christiansen, C. Gjerstad, and B. M. Iversen
Age-dependent regulation of vasopressin V1a receptors in preglomerular vessels from the spontaneously hypertensive rat
Am J Physiol Renal Physiol, May 1, 2004; 286(5): F997 - F1003.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Just, A. J. M. Olson, and W. J. Arendshorst
Dual constrictor and dilator actions of ETB receptors in the rat renal microcirculation: interactions with ETA receptors
Am J Physiol Renal Physiol, April 1, 2004; 286(4): F660 - F668.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. E. Purdy and W. J. Arendshorst
EP1 and EP4 receptors mediate prostaglandin E2 actions in the microcirculation of rat kidney
Am J Physiol Renal Physiol, October 1, 2000; 279(4): F755 - F764.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
O. Vagnes, J. J. Feng, B. M. Iversen, and W. J. Arendshorst
Upregulation of V1 receptors in renal resistance vessels of rats developing genetic hypertension
Am J Physiol Renal Physiol, June 1, 2000; 278(6): F940 - F948.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. E. Purdy and W. J. Arendshorst
Prostaglandins buffer ANG II-mediated increases in cytosolic calcium in preglomerular VSMC
Am J Physiol Renal Physiol, December 1, 1999; 277(6): F850 - F858.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
X. Ruan, C. Chatziantoniou, and W. J. Arendshorst
Impaired Prostaglandin E2/Prostaglandin I2 Receptor-Gs Protein Interactions in Isolated Renal Resistance Arterioles of Spontaneously Hypertensive Rats
Hypertension, November 1, 1999; 34(5): 1134 - 1140.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. K. Jackson, W. A. Herzer, Z. Mi, S. J. Vyas, and C. K. Kost Jr
Low-Dose Angiotensin II Reduces Urinary Cyclic AMP Excretion in Spontaneously Hypertensive, But Not Normotensive, Rats: Independence from Hypertension and Renal Hemodynamic Effects of Angiotensin
J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 115 - 123.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
E. K. Jackson, W. A. Herzer, S. J. Vyas, and C. K. Kost Jr
Angiotensin II-Induced Renal Vasoconstriction in Genetic Hypertension
J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 329 - 334.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
J. Zicha and J. Kunes
Ontogenetic Aspects of Hypertension Development: Analysis in the Rat
Physiol Rev, October 1, 1999; 79(4): 1227 - 1282.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. Brannstrom and W. J. Arendshorst
Resetting of exaggerated tubuloglomerular feedback activity in acutely volume-expanded young SHR
Am J Physiol Renal Physiol, March 1, 1999; 276(3): F409 - F416.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
B. M. Iversen and W. J. Arendshorst
Exaggerated Ca2+ signaling in preglomerular arteriolar smooth muscle cells of genetically hypertensive rats
Am J Physiol Renal Physiol, February 1, 1999; 276(2): F260 - F270.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Mokkapatti, S. J. Vyas, G. G. Romero, Z. Mi, T. Inoue, R. K. Dubey, D. G. Gillespie, A. K. Stout, and E. K. Jackson
Modulation by Angiotensin II of Isoproterenol-Induced cAMP Production in Preglomerular Microvascular Smooth Muscle Cells from Normotensive and Genetically Hypertensive Rats
J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 223 - 231.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. J. Vyas, R. Mokkapatti, R. K. Dubey, M. R. Chinoy, and E. K. Jackson
Guanine Nucleotide-Binding Inhibitory Protein-Mediated Inhibition of Adenylyl Cyclase Is Enhanced in Spontaneously Hypertensive Rat Preglomerular Arteriolar Smooth Muscle Cells
J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 828 - 834.
[Abstract] [Full Text]


Home page
HypertensionHome page
U. C. Kopp, M. Z. Cicha, D. M. Farley, L. A. Smith, and B. S. Dixon
Renal Substance P–Containing Neurons and Substance P Receptors Impaired in Hypertension
Hypertension, March 1, 1998; 31(3): 815 - 822.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Mokkapatti, S. J. Vyas, and E. K. Jackson
G protein mRNA expression in renal microvessels from spontaneously hypertensive and Wistar-Kyoto rats
Am J Physiol Renal Physiol, December 1, 1997; 273(6): F877 - F882.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. J. Feng and W. J. Arendshorst
Calcium Signaling Mechanisms in Renal Vascular Responses to Vasopressin in Genetic Hypertension
Hypertension, November 1, 1997; 30(5): 1223 - 1231.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. Notoya, M. Nakamura, and K. Mizojiri
Effects of Lisinopril on the Structure of Renal Arterioles
Hypertension, March 1, 1996; 27(3): 364 - 370.
[Abstract] [Full Text]


Home page
HypertensionHome page
U. C. Kopp and L. A. Smith
Bradykinin and Protein Kinase C Activation Fail to Stimulate Renal Sensory Neurons in Hypertensive Rats
Hypertension, March 1, 1996; 27(3): 607 - 612.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online